the same period of last year and a decrease of 5.28% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales. 2. Cost of sales was 384.25
the same period of last year and a decrease of 30.49% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales caused from the COVID-19 out
5.94 million, dropping off by Baht 3.70 million from last year due to share of loss from KT ZMICO Securities Co., Ltd. (“KT ZMICO”) of Baht 4.64 million (The Company holds 49.71%). The loss was mainly
provide household tasks. On the contrary, in 2018, the Company was no one-time expense regarding listed on the Stock Exchange of Thailand . Financing Costs The financing costs of financial institutions for
administrative expenses derived mainly from expenses related to employees and also hiring outsourcing company to provide household tasks. On the contrary, in 2018, the Company was no one-time expense regarding
expense. On the contrary, net investment income, gain on investment and fair value gains totally amount to THB 25.45 million. An increase of THB 14.08 million (123.7%) relatively to last year figure. This
asymmetry of permanent and temporary price impact between buy trades and sell trades is determined primarily by market conditions. Specifically, contrary to the findings in previous studies, the results show
sales of 4rd quarter on 2018 decreased 15.08 percent due to decreasing in sale volume and decreasing in sale price, result in dropping in revenue from sales, while other income of 4rd quarter on 2018
. The revenue from In-patients department inclined by 27.9%, on the contrary, Out-patients department inclined by 20.3%. The number of both out-patient and in-paient were increased to 19.3% and 34.2
were stemmed from both Wattanapat Hospital Trang Public Company Limited and its subsidiary. The revenue from Out-patients department was inclined by 20.1%, on the contrary, In-patients department was